Login
Remember
Login
Register
I forgot my password
Q&A
Questions
Recent
Hot!
Most votes
Most answers
Most views
Unanswered
No answer
No selected answer
No upvoted answer
Tags
Users
Ask a Question
User crookcircle50
User crookcircle50
Wall
Recent activity
All questions
All answers
User crookcircle50
Wall
Recent activity
All questions
All answers
Member for:
6 days (since Sep 22)
Type:
Registered user
Full name:
Location:
About:
Inadequate efficiency standing individual along with long-lasting significant response to pembrolizumab in sophisticated non-small-cell lung cancer along with coexisting Person of polish lineage mutation as well as lacking mismatch restore walkway.
Activity by crookcircle50
Score:
100
points (ranked #
45
)
Questions:
0
Answers:
0
Comments:
0
Voted on:
0
questions,
0
answers
Gave out:
0
up votes,
0
down votes
Received:
0
up votes,
0
down votes
Wall for crookcircle50
Please
log in
or
register
to post on this wall.
